Hope for fatty liver patients as new drug shows Life-Saving Potential
In order to treat metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease associated with obesity and type 2 diabetes that can result in cirrhosis, liver failure, and…
